Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

Enrollment Performance

Analytics

No phase data available

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT07504406Not Yet Recruiting

Assessment of Medication Adherence in Ccu Admitted Patients

Role: lead

NCT07473492Not Yet Recruiting

Assessment of Malnutrition in Hospitalized Patients: a Quasi Study

Role: lead

NCT04800861Completed

Glycemic Control in Diabetic Hospitalized Patients

Role: lead

NCT05256602Unknown

Prevalence of Knowledge, Attitudes and Perception of Covid Vaccine in Iraq. A Cross Sectional Study

Role: lead

All 4 trials loaded